Rer1-mediated quality control system is required for neural stem cell maintenance during cerebral cortex development

PLoS Genet. 2018 Sep 27;14(9):e1007647. doi: 10.1371/journal.pgen.1007647. eCollection 2018 Sep.

Abstract

Rer1 is a retrieval receptor for endoplasmic reticulum (ER) retention of various ER membrane proteins and unassembled or immature components of membrane protein complexes. However, its physiological functions during mammalian development remain unclear. This study aimed to investigate the role of Rer1-mediated quality control system in mammalian development. We show that Rer1 is required for the sufficient cell surface expression and activity of γ-secretase complex, which modulates Notch signaling during mouse cerebral cortex development. When Rer1 was depleted in the mouse cerebral cortex, the number of neural stem cells decreased significantly, and malformation of the cerebral cortex was observed. Rer1 loss reduced γ-secretase activity and downregulated Notch signaling in the developing cerebral cortex. In Rer1-deficient cells, a subpopulation of γ-secretase complexes and components was transported to and degraded in lysosomes, thereby significantly reducing the amount of γ-secretase complex on the cell surface. These results suggest that Rer1 maintains Notch signaling by maintaining sufficient expression of the γ-secretase complex on the cell surface and regulating neural stem cell maintenance during cerebral cortex development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Vesicular Transport
  • Amyloid Precursor Protein Secretases / metabolism*
  • Animals
  • Behavior, Animal
  • CRISPR-Cas Systems / genetics
  • Cell Line, Tumor
  • Cerebral Cortex / growth & development*
  • Cerebral Cortex / metabolism
  • Chromosome Deletion
  • Chromosome Disorders / genetics
  • Chromosomes, Human, Pair 1 / genetics
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation, Developmental*
  • Humans
  • Lysosomes / metabolism
  • Male
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism*
  • Mice
  • Mice, Knockout
  • Neural Stem Cells
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Receptors, Cytoplasmic and Nuclear / metabolism*
  • Receptors, Notch / metabolism

Substances

  • Adaptor Proteins, Vesicular Transport
  • Membrane Glycoproteins
  • RER1 protein, human
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Notch
  • Rer1 protein, mouse
  • Amyloid Precursor Protein Secretases

Supplementary concepts

  • Chromosome 1p36 Deletion Syndrome

Grants and funding

TH was supported by research grants from the Takeda Science Foundation(http://www.takeda-sci.or.jp/), the Nakajima Foundation(http://www.nakajimafound.or.jp/), the Astellas Foundation for Research on Metabolic Disorders(https://www.astellas.com/jp/byoutai/), and MEXT JSPS KAKENHI (Grant Number:17K08621(https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-17K08621), 15K19002 (https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15K19002/),24116702 (https://kaken.nii.ac.jp/grant/KAKENHI-PUBLICLY-24116702/), and 24590341(https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24590341/). This research is also supported by the research program for conquering intractable disease from Japan Agency for Medical Research and Development, AMED(Grant Number 26310301, http://www.amed.go.jp/en/) and is a part pf the outcome of research performed under a Waseda University Grant for Special Research Project (Project number: 2017S-142 and 2018K-349). KS was supported by the JSPS KAKENHI (Grant Number: 17K19377, 17H03669), the Uehara Memorial Foundation, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.